Fuula Jalqabaa › Tajaajiltoota › International AIDS Vaccine Initiative (IAVI)
International AIDS Vaccine Initiative (IAVI): Baajannaa H-1B fi deggera
International AIDS Vaccine Initiative (IAVI) iyyannoo hojii haala 11 H-1B fi viizaa walitti dhufeenya qaban bara maallaqaa 2023–2026 irratti galche; mirkaneessame: 11. Baajannaa giddugaleessaa dhiyaate: $163,800.
International AIDS Vaccine Initiative (IAVI) viizaa H-1B deggeraa?
International AIDS Vaccine Initiative (IAVI) bara maallaqaa 2023–2026 irratti iyyannoo hojii haala 11 galche, kan haaraan 26-Cam-2026 irratti dhiyaate. LCA tarsiimoo jalqabaa iyyannoo H-1B ti, hojii kennaan hojjettoota H-1B deggereera yookaan deggeruuf qophii ta'eera; hojii adda addaaf deggera hin mirkaneessu. Galmee hojii hojii kennaa isaa ilaali.
Baajannaa maqaa hojii irratti
| Mata-duree hojii | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | 2 | $113,916 |
| Medical Director, Early-Stage Clinical Development | 2 | $225,000 |
| Director, Regulatory Affairs | 2 | $166,860 |
| Specialist, Talent Development | 1 | $72,800 |
| PD Associate, HIV Antibody Discovery & Vaccine Responses | 1 | $80,000 |
| Research Scientist II, Antibody Optimization | 1 | $110,000 |
| Associate Director, CMC Recombinant Protein Development | 1 | $163,800 |
| Director, Project Management | 1 | $192,000 |
Iyyannoo bara maallaqaa irratti
| Bara maallaqaa | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| FY2023 | 1 | $110,000 |
| FY2024 | 4 | $152,500 |
| FY2025 | 5 | $166,860 |
| FY2026 | 1 | $117,832 |
Sadarkaa baajannaa olaanaa
Dhaabbanni Hojii sadarkaa baajannaa olaanaa afur hojii tokkoo tokkoo fi bakkaaf, Sadarkaa I (jalqabaa) hanga Sadarkaa IV (guddisaa) jiru, kaa'a. Hojii kennaan sadarkaa hojii sanaaf madaalu filata.
Hojiiwwan eessa jiru
- La Jolla, CA2
- San Diego, CA2
- Skillman, NJ2
- New York, NY1
- Pearland, TX1
- San Benito, TX1
- Rockville, MD1
- Sacramento, CA1
Hojiiwwan
- Medical Scientists, Except Epidemiologists5
- Regulatory Affairs Specialists2
- Human Resources Specialists1
- Microbiologists1
- Bioengineers and Biomedical Engineers1
- Natural Sciences Managers1
Iyyannoo haaraa
| Mata-duree hojii | Baasii bu'uuraa | Bakka | Dhiyaate | Guyyaa jalqabaa | Haala |
|---|---|---|---|---|---|
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | $117,832 Sadarkaa II | La Jolla, CA | 26-Cam-2026 | 05-Ado-2026 | Mirkaneffame |
| Director, Regulatory Affairs | $166,860 Sadarkaa IV | Skillman, NJ | 02-Ful-2025 | 01-Sad-2025 | Mirkaneffame |
| Director, Regulatory Affairs | $166,860 Sadarkaa IV | Skillman, NJ | 23-Ado-2025 | 03-Onk-2025 | Mirkaneffame |
| Director, Project Management | $192,000 Sadarkaa IV | Sacramento, CA | 27-Wax-2025 | 03-Onk-2025 | Mirkaneffame |
| Associate Director, CMC Recombinant Protein Development | $163,800 Sadarkaa IV | Rockville, MD | 02-Elb-2025 | 20-Wax-2025 | Mirkaneffame |
| Research Scientist II, Antibody Optimization | $110,000 Sadarkaa II | San Diego, CA | 19-Sad-2024 | 01-Cam-2025 | Mirkaneffame |
| Medical Director, Early-Stage Clinical Development | $225,000 Sadarkaa IV | Pearland, TX | 23-Ado-2024 | 09-Ful-2024 | Mirkaneffame |
| Medical Director, Early-Stage Clinical Development | $225,000 Sadarkaa IV | San Benito, TX | 17-Ado-2024 | 09-Ful-2024 | Mirkaneffame |
| Specialist, Talent Development | $72,800 Sadarkaa II | New York, NY | 08-Gur-2024 | 13-Cam-2024 | Mirkaneffame |
| PD Associate, HIV Antibody Discovery & Vaccine Responses | $80,000 Sadarkaa I | San Diego, CA | 08-Ama-2024 | 04-Bit-2024 | Mirkaneffame |
| Research Scientist II, Antibody Disc. & B-Cell Resp. Eval. | $110,000 Sadarkaa IV | La Jolla, CA | 03-Cam-2023 | 05-Ado-2023 | Mirkaneffame |
Baajanni gatii gadii gatii hojii iyyannoo tokkoo tokkoon irratti dhiyaate yoo ta'u, gara baajannaa waggaatti jijjiirame; lakkoofsa hojii guutuu hamma guyyaa guutuu qofa fayyadama. LCA mirkaneessa viizaa miti; LCA tokko hojii hedduu haguuchuuf ni danda'a. Madda: Dhaabbata Hojii Ameerikaa, OFLC LCA Disclosure Data, bara maallaqaa 2023–2026 (murtii haaraa 30-Wax-2026).